Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R2-B for Relapsed/Refractory Mantle Cell Lymphoma
NCT01737177Phase 2Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Jul 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in mantle cell lymphoma (MCL), sponsored by Fondazione Italiana Linfomi. Started Jul 2012; status: completed.
02
Drugs
lenalidomide
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT01737177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01737177.